Australia markets closed

HealthEquity, Inc. (HQY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
79.21+0.81 (+1.03%)
At close: 04:00PM EDT
78.25 -0.96 (-1.21%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.75B
Enterprise value 7.28B
Trailing P/E 122.50
Forward P/E 24.39
PEG ratio (5-yr expected) 1.32
Price/sales (ttm)6.82
Price/book (mrq)3.32
Enterprise value/revenue 7.29
Enterprise value/EBITDA 25.69

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 338.10%
S&P500 52-week change 326.36%
52-week high 384.49
52-week low 354.09
50-day moving average 380.04
200-day moving average 373.70

Share statistics

Avg vol (3-month) 3567.19k
Avg vol (10-day) 3609.87k
Shares outstanding 586.16M
Implied shares outstanding 686.76M
Float 884.51M
% held by insiders 12.22%
% held by institutions 1102.21%
Shares short (30 Apr 2024) 42.93M
Short ratio (30 Apr 2024) 45.27
Short % of float (30 Apr 2024) 43.95%
Short % of shares outstanding (30 Apr 2024) 43.40%
Shares short (prior month 28 Mar 2024) 42.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2024
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 5.57%
Operating margin (ttm)15.69%

Management effectiveness

Return on assets (ttm)2.56%
Return on equity (ttm)2.84%

Income statement

Revenue (ttm)999.59M
Revenue per share (ttm)11.68
Quarterly revenue growth (yoy)12.20%
Gross profit (ttm)N/A
EBITDA 281.21M
Net income avi to common (ttm)55.71M
Diluted EPS (ttm)0.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)403.98M
Total cash per share (mrq)4.69
Total debt (mrq)933.14M
Total debt/equity (mrq)45.85%
Current ratio (mrq)4.76
Book value per share (mrq)23.63

Cash flow statement

Operating cash flow (ttm)242.83M
Levered free cash flow (ttm)211.89M